MYELOMA INVESTMENT FUND Trademark

Trademark Overview

On Wednesday, May 27, 2020, a trademark application was filed for MYELOMA INVESTMENT FUND with the United States Patent and Trademark Office. The USPTO has given the MYELOMA INVESTMENT FUND trademark a serial number of 88935517. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, February 24, 2026. This trademark is owned by The Multiple Myeloma Research Foundation, Inc.. The MYELOMA INVESTMENT FUND trademark is filed in the Insurance & Financial Services category with the following description:

Investment of funds; Management of a capital investment fund
myeloma investment fund

General Information

Serial Number88935517
Word MarkMYELOMA INVESTMENT FUND
Filing DateWednesday, May 27, 2020
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, February 24, 2026
Registration Number6171763
Registration DateTuesday, October 6, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesInvestment of funds; Management of a capital investment fund

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, June 16, 2020
Primary Code036
First Use Anywhere DateTuesday, April 16, 2019
First Use In Commerce DateTuesday, April 16, 2019

Trademark Owner History

Party NameThe Multiple Myeloma Research Foundation, Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNorwalk, CT 06851
US
Party NameThe Multiple Myeloma Research Foundation, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNorwalk, CT 06851
US

Trademark Events

Event DateEvent Description
Saturday, May 30, 2020NEW APPLICATION ENTERED
Tuesday, June 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 11, 2020ASSIGNED TO EXAMINER
Thursday, August 13, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, August 13, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, August 13, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 13, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, August 13, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, August 21, 2020ASSIGNED TO LIE
Monday, August 31, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 6, 2020REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, August 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 6, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 6, 2025TEAS SECTION 8 RECEIVED
Monday, February 23, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 24, 2026REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, February 24, 2026NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

fund investment myeloma capital management funds